| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/30/1999 | EP0925061A1 Compositions comprising microparticles of water-insoluble substances and method for preparing same |
| 06/30/1999 | EP0925060A1 Fast decomposing pellets |
| 06/30/1999 | EP0925059A1 Protein-lipid vesicles and autogenous vaccine comprising the same |
| 06/30/1999 | EP0924996A1 Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts |
| 06/30/1999 | EP0755248B1 Gelified microspheres, method of preparation and applications |
| 06/30/1999 | EP0612521B1 Fomentation containing ketorolac |
| 06/30/1999 | EP0526540B1 Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke |
| 06/30/1999 | CN1221398A 甘露糖醇及其制备 Mannitol and its preparation |
| 06/30/1999 | CN1221364A Chucks and methods for positioning multiple objects on a substrate |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221338A Use of H2-antagonists for manufacture of topical composition for treatment of colds |
| 06/30/1999 | CN1221337A Liquisolid system and method of preparing the same |
| 06/30/1999 | CN1221334A Detergent composition for skin |
| 06/30/1999 | CN1220892A Formula of Chinese medicine preparation for treating heart disease and preparation method thereof |
| 06/30/1999 | CN1220891A Formula of large plaster for treating breast furuncle scrofula, prolapse of lumbar intervertebral disc and making method thereof |
| 06/30/1999 | CN1220889A Formula of plaster for quick treatment of rheumatalgia and making method |
| 06/30/1999 | CN1220887A Acupoint traditional Chinese medicine plaster for delivering |
| 06/30/1999 | CN1220874A Drug composition with controlled drug release rate |
| 06/30/1999 | CN1220873A Method for manufacture troche for eliminating gastrointestinal vesicle and its application |
| 06/30/1999 | CN1043893C Pharmaceuticals |
| 06/30/1999 | CA2243378A1 Method and device for infant male circumcision anesthesia |
| 06/29/1999 | US5917081 Process and apparatus for the agglomeration of hydrolytically sensitive substances by means of steam |
| 06/29/1999 | US5916998 For use as matrix supports for controlled drug delivery |
| 06/29/1999 | US5916968 Adhesives resistant to skin-penetration enhancers |
| 06/29/1999 | US5916918 Bedsore |
| 06/29/1999 | US5916885 Treatment of psoriasis, dermatitis |
| 06/29/1999 | US5916790 Encapsulation compositions, and methods |
| 06/29/1999 | US5916598 First and second phases are combined to form an emulsion in which the first phase is discontinuous and the second phase is continuous. the phases are immersed in a quench liquid. |
| 06/29/1999 | US5916597 Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916595 HMG co-reductase inhibitor |
| 06/29/1999 | US5916594 Rapidly dissolving, orally administerable, with high tap density used to treat hepatitis c |
| 06/29/1999 | US5916593 Process of making dosage units by wet granulation |
| 06/29/1999 | US5916592 Subcoated simulated capsule-like medicament |
| 06/29/1999 | US5916591 Soft gelatin capsules |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | US5916589 Pharmaceutical compositions comprising cyclosporins |
| 06/29/1999 | US5916588 Dosage forms |
| 06/29/1999 | US5916587 Transdermal delivery matrix for piroxicam |
| 06/29/1999 | US5916584 Controlled release container with core and outer shell |
| 06/29/1999 | US5916583 Precipitation of one or more active compounds in situ |
| 06/29/1999 | US5916582 Aqueous formulations of peptides |
| 06/29/1999 | US5916581 Iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
| 06/29/1999 | US5916567 Powdered inner seed and powdered fibrous outer shell subjected to radiation |
| 06/29/1999 | US5916566 Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
| 06/29/1999 | US5916554 Insulin |
| 06/29/1999 | US5916550 C2-7 aliphatic amino acid is added to an aqueous suspension of loteprednol etabonate for topical ophthalmic use, the suspension does not undergo ph depression even on prolonged storage, with the result that no irritable response is |
| 06/29/1999 | US5916540 Aerosol formulations containing P134A and/or P227 and particulate medicament |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | US5916371 Crystalline powdery saccsharide, its preparation and uses |
| 06/29/1999 | US5915378 Creating an aerosolized formulation of insulin |
| 06/29/1999 | CA2255202A1 Use of flavin adenine dinucleotide in the preparation of ophthalmic formulations for the treatment of dry eye |
| 06/29/1999 | CA2156063C Sucrose ester c-20 to c-28 alcohol formulations |
| 06/29/1999 | CA2132936C Stabilized pharmaceutical compositions and stabilizing solvent |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/29/1999 | CA2109403C Preparations containing a fluorocarbon emulsion and usable as cosmetics or dermatics |
| 06/29/1999 | CA2098727C Device for delivering an aerosol |
| 06/29/1999 | CA2097823C Therapy for pulmonary vasoconstriction and asthma |
| 06/29/1999 | CA2048200C Polylactide in a purified state, method for the production therof, and pharmaceutical compositions |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999030764A1 Systems and methods for local delivery of an agent |
| 06/24/1999 | WO1999030749A1 Use of odorants to alter vaginal blood flow, and article of manufacture therefor |
| 06/24/1999 | WO1999030740A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | WO1999030737A1 Use of microparticles combined with submicron oil-in-water emulsions |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030728A1 Pharmaceutical compositions based on dalforpristin and quinupristin and preparation |
| 06/24/1999 | WO1999030714A1 Sustained-release theophylline preparation and process for producing the same |
| 06/24/1999 | WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 06/24/1999 | WO1999030702A1 Percutaneously absorbable levodopa-containing preparation |
| 06/24/1999 | WO1999030694A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 06/24/1999 | WO1999030693A2 A double capsule for the administration of active principles in multiple therapies |
| 06/24/1999 | WO1999030692A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION |
| 06/24/1999 | WO1999030691A2 Composition for the controlled release of active compounds |
| 06/24/1999 | WO1999030690A1 Oral delivery formulation |
| 06/24/1999 | WO1999030689A1 Pharmaceutical suspension tablet compositions |
| 06/24/1999 | WO1999030688A1 Methods of lyophilizing solutions |
| 06/24/1999 | WO1999030687A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | WO1999030686A1 Cationic drugs encapsulated in anionic liposomes |
| 06/24/1999 | WO1999030685A1 Polymeric microporous film coated subcutaneous implants |
| 06/24/1999 | WO1999030683A1 Preparation with a prolonged retention time at the site of application |
| 06/24/1999 | WO1999030671A2 Aspected particles for oral delivery |
| 06/24/1999 | WO1999030580A1 Method and device for improving the efficiency of active agents consisting at least of mineral substances |
| 06/24/1999 | WO1999030570A1 Animal feed pelleting process and animal feed pellets produced therefrom |
| 06/24/1999 | WO1999030560A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| 06/24/1999 | DE19849228A1 Use of compositions containing vitamin E and chitosan |
| 06/24/1999 | DE19845246A1 Vitamin E compositions |
| 06/24/1999 | DE19757301A1 Intra-nasal vaccine against yellow fever |
| 06/24/1999 | DE19756677A1 Per-oral dry plant extract |
| 06/24/1999 | DE19756314A1 Zubereitung mit verlängerter Verweildauer am Applikationsort Preparation with prolonged residence time at the site of application |
| 06/24/1999 | CA2586240A1 Improved hmg coa reductase inhibitor extended release formulation |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2315224A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | CA2314968A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/23/1999 | EP0923953A2 Drug coating with topcoat |
| 06/23/1999 | EP0923943A1 Micellar aqueous composition and method for solubilizing hydrophobic drug |